Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis. Marrocco GA, Silletta M, Bianco V, Mondera F, et al. Anticancer Res 2023;43:755-763.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marrocco GA, Silletta M, Bianco V, Mondera F, et al. Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis. Anticancer Res 2023;43:755-763.
PMID: 36697101